Does Genetic Diversity of HIV-1 Non-B Subtypes Differentially Impact Disease Progression in Treatment-Naive HIV-1–Infected Individuals? A Systematic Review of Evidence: 1996–2010

With 88% of HIV-1–infected individuals living in areas of high prevalence of non–B subtypes and with expanded global access to antiretroviral treatment (ART), studying disease progression amongst non–B subtypes gains relevance. Optimized clinical management is a possibility with knowledge of non–B s...

Ausführliche Beschreibung